Company: HURA
Filing Date: 2025-12-10
Form Type: 424B5
Source: 0001193125-25-313799
Chunk: 16

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-12-10
Form: 424B5
Chunk 16
---
, as liquidated damages and not as a penalty, for each $1,000 of shares subject to such exercise, $10 per trading day (increasing to $20 per
trading day on the third trading day after such liquidated damages begin to accrue) for each trading day after the trading day on which such shares were required to be delivered, until such shares are delivered or the investor rescinds such
exercise.

Fundamental Transaction

In the event of a fundamental transaction, as described in the Warrants and generally including any reorganization, recapitalization or
reclassification of our shares of Common Stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of the
outstanding Common Stock or more than 50% of the voting power of the common equity of the Company, any person or group becoming the beneficial owner of more than 50% of the outstanding Common Stock or more than 50% of the voting power of the common
equity of the Company, any merger with or into another entity or a tender offer or exchange offer approved by more than 50% of the outstanding Common Stock or more than 50% of the voting power of the common equity of the Company, then upon any
subsequent exercise of a Warrant, the holder will have the right to receive as alternative consideration, for each share of our Common Stock that would have been issuable upon such exercise immediately prior to the occurrence of such fundamental
transaction, the number of shares of Common Stock of the successor or acquiring corporation or of our company, if it is the surviving corporation, and any additional consideration receivable upon or as a result of such transaction by a holder of the
number of shares of our Common Stock for which the Warrant is exercisable immediately prior to such event. In addition, in the event of

S-12

a Fundamental Transaction, in certain circumstances the holder may choose to require the Company, or its successor, to redeem the Warrant for cash in the amount of the Black-Scholes value of the
remaining unexercised portion of the Warrant.

Placement Agent Warrants

We have also agreed to issue to the lead placement agent (or its designee) the Placement Agent Warrants to purchase up to 283,873 shares of
Common Stock as compensation in connection with this offering. The Placement Agent Warrants will be exercisable starting six months after issuance